HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

hCRF

WITHDRAWN · PHASE3 · Brain Edema, Brain Tumor

Alternate study projected to assess imaging endpoints versus clinical endpoints.

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.